Metabolic Research Peptides

Incretin-based research peptides for studies on metabolic regulation, adiposity and glycaemic control. Retatrutide (LY3437943) as the first GLP-1/GIP/glucagon triple agonist with up to 24 percent weight loss in Phase 2 (NEJM 2023) and positive Phase 3 readouts from TRIUMPH-4. Alongside it, AOD-9604 as hGH fragment 176-191 for targeted lipolysis research without systemic incretin activity. Both compounds are Janoshik-tested, EU warehouse, DHL premium shipping with a reduced 8-euro rate inside Germany.

Featured in this category

AOD-9604

Modified hGH fragment (176-191) studied for fat metabolism and lipolysis research. Interacts with beta-3 adrenergic receptors without growth-promoting effects.

from €49.99View product →

Retatrutide

First-ever triple-action weight management peptide targeting three receptors at once: GLP-1, GIP, and glucagon. Shown exceptional results in Phase 2 trials - up to 24% weight reduction. The most advanced metabolic peptide available.

from €149.99View product →

All products

-10%

Metabolic

AOD-9604

Modified hGH fragment (176-191) studied for fat metabolism and lipolysis research. Interacts with beta-3 adrenergic receptors without growth-promoting effects.

€89.99

-17%